Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey

PURPOSE: To describe changes due to the COVID-19 pandemic in the prescribing of long-acting antipsychotics (LAI) for schizophrenia, patient outcomes, and patient and healthcare provider (HCP) attitudes regarding COVID-19 vaccination in the United States (US). METHODS: An anonymous online survey was...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhdanava, Maryia, Starr, H Lynn, Totev, Todor I, Lefebvre, Patrick, Shah, Aditi, Sheng, Kristy, Pilon, Dominic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464453/
https://www.ncbi.nlm.nih.gov/pubmed/36101838
http://dx.doi.org/10.2147/NDT.S379985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464453/
https://www.ncbi.nlm.nih.gov/pubmed/36101838
http://dx.doi.org/10.2147/NDT.S379985

Ejemplares similares